RNA, 7SL, cytoplasmic 116, pseudogene (RN7SL116P)

RN7SL116P is classified as a pseudogene derived from the 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP)[1][5]. The SRP is a ribonucleoprotein complex essential for co-translational targeting of nascent secretory and membrane proteins to the endoplasmic reticulum[3][4]. However, RN7SL116P itself does not produce a functional RNA or protein and is not known to be expressed or to have any direct biological activity or disease association. Pseudogenes like RN7SL116P arise when sequences of functional RNA genes, such as 7SL RNA, are reverse transcribed and integrated into new chromosomal sites, often becoming truncated and losing their functional capacity[5]. Most 7SL-related pseudogenes are considered genomic "fossils" without therapeutic relevance and are not recognized as drug targets, receptors, enzymes, or disease biomarkers[1][5]. Notable Issues: - RN7SL116P is not a therapeutic target—it is a pseudogene with no demonstrated biological function, involvement in disease, or drug interaction[1][5]. - No evidence exists that this pseudogene acts as a biomarker, safety risk, or has any functional roles. - Structured information such as molecular classification, mechanism of action, and drug interactions are not applicable to pseudogenes, so those entries should be considered null for RN7SL116P. If you require information on the functional 7SL RNA gene (e.g., RN7SL1), which is part of the signal recognition particle and has established biological functions and disease roles, please specify. RN7SL116P refers specifically to a non-functional pseudogene copy and not the active component of SRP[1][5].

Other names

RN7SL116P7SL RNA pseudogene 116